Bicyclo[3.1.0]hexan-2-one, 98%, 250mg

((3aR,4R,6R,6aR)-6-(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2,2,3a-trimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methanol, 98%, 5g

2-Ethylcyclohexan-1-one, 97%, 10g

(R)-[1,1'-Binaphthalene]-2,2'-diyl bis(trifluoromethanesulfonate), 98%, 10g

1-(2-chlorobenzoyl)-1,4-diazepane, 95.0%, 2g

4-methylthiophene-2-sulfonyl chloride, 95.0%, 250mg

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 25 m, Ø-Innen 0,20 mm, Filmd. 0,10 µm, 1 Stück

Ethyl 2-Fluoroacetoacetate>95.0%(GC)25g

2,4-Difluorobenzaldehyde>98.0%(GC)25g

METHYL FURO[3,2-B]PYRIDINE-6-CARBOXYLATE, 95.0%, 100mg

Dipropylenglykol, min. 99 %, rein, 2.5 l, kunststoffverpackung.

2-(trifluoromethoxy)benzamidoxime, 95.0%, 1g

TERT-BUTYL 4-OXO-1-OXA-8-AZASPIRO[4.5]DECANE-8-CARBOXYLATE, 95.0%, 1g